Insulin
Insulin Therapy
Bile Acid Sequestrant
Assessment of the Treatment Regimen
Overview of Pharmacologic Therapy
Large differences observed among insulin algorithms at US academic hospitals
Algorithms for initiating insulin among noncritically ill adults varied widely across 20 U.S. academic hospitals, according to a brief report published in Diabetes Technology & Therapeutics.
Postprandial insulin may cut hypoglycemia rates for hospitalized adults with diabetes
Changing in-hospital nutritional insulin administration from before meals to after meals lowered hypoglycemia rates at a community hospital, according to study findings published in Diabetes Research and Clinical Practice.
Top in endocrinology: Tirzepatide vs. semaglutide; FDA rejects icodec for diabetes
Researchers found that adults with overweight or obesity lost more weight with tirzepatide than semaglutide in a head-to-head comparison of the medications using electronic medical records data.
FDA rejects once-weekly basal insulin for diabetes, requests more information
The FDA declined to approve once-weekly basal insulin icodec for the treatment of diabetes and is requesting more information from Novo Nordisk, according to a company press release.
GLP-1s tied to lower risk for 10 types of cancer compared with insulin in type 2 diabetes
People with type 2 diabetes who use a GLP-1 receptor agonist have a lower risk for 10 types of obesity-associated cancer compared with those who use insulin, according to data published in JAMA Network Open.
Insulin adjustments suggested by mobile app cut HbA1c for adults with type 1 diabetes
ORLANDO — Adults with type 1 diabetes had larger reductions in HbA1c using a mobile app that made recommended adjustments to insulin therapy than users who did not receive weekly adjustments, according to a speaker.